Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
kunning oral liquid
- Development stage
- Unknown
- Lead developer
- Yantai Rongchang Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Kunning Oral Liquid is a Traditional Chinese Medicine (TCM) compound formulation widely utilized in gynecological practice in China. It is primarily indicated for the treatment of abnormal uterine bleeding, postpartum hemorrhage, and menstrual irregularities associated with blood stasis. The preparation is composed of several botanical extracts, including *Leonurus japonicus* (Motherwort), *Panax notoginseng*, and *Angelica sinensis*, which collectively exert hemostatic, anti-inflammatory, and analgesic effects. In clinical research, such as studies sponsored by Beijing Friendship Hospital, Kunning Oral Liquid is being evaluated for its potential to prevent the recurrence of intrauterine adhesions (IUA) following transcervical resection of adhesions (TCRA). The drug is hypothesized to promote endometrial repair and modulate inflammatory responses to inhibit the fibrotic processes that lead to adhesion formation.
- Brand names
- Kunning Oral Liquid坤宁口服液Kunning
- Other names
- Kunning KoufuyeKunning Oral Solution
Beyond the preview
Go deeper on kunning oral liquid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on kunning oral liquid.